At the time of writing, Neuronetics Inc [STIM] stock is trading at $1.99, up 2.84%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The STIM shares have gain 10.56% over the last week, with a monthly amount glided 40.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neuronetics Inc [NASDAQ: STIM] stock has seen the most recent analyst activity on August 13, 2024, when William Blair downgraded its rating to a Mkt Perform. Previously, William Blair downgraded its rating to Mkt Perform on October 13, 2021. On October 13, 2021, downgrade downgraded it’s rating to Neutral. William Blair upgraded its rating to a Outperform. BTIG Research initiated its recommendation with a Buy and recommended $11 as its price target on February 06, 2020.
For the past year, the stock price of Neuronetics Inc fluctuated between $1.25 and $5.92. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Neuronetics Inc [NASDAQ: STIM] shares were valued at $1.99 at the most recent close of the market. An investor can expect a potential return of 302.01% based on the average STIM price forecast.
Analyzing the STIM fundamentals
According to Neuronetics Inc [NASDAQ:STIM], the company’s sales were 129.87M for trailing twelve months, which represents an 101.28% jump. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.29%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -1.51 and Total Capital is -0.32. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Neuronetics Inc [NASDAQ:STIM] has a current ratio of 2.24. Also, the Quick Ratio is 2.09, while the Cash Ratio stands at 1.19. Considering the valuation of this stock, the price to sales ratio is 1.05, the price to book ratio is 4.98.
Transactions by insiders
Recent insider trading involved Madryn Asset Management, LP, 10% Owner, that happened on Aug 08 ’25 when 3.5 million shares were sold. 10% Owner, MADRYN HEALTH PRTS II (CAY MAS completed a deal on Aug 08 ’25 to buy 2.93 million shares. Meanwhile, 10% Owner MADRYN HEALTH PARTNERS II, LP bought 0.19 million shares on Aug 08 ’25.
